Cervical Dysplasia Global Clinical Trials Review, H2, 2012 Market, Trends, Share, Size Research Report

Home
Pharmaceutical
Cervical Dysplasia Global Clinical Trials Review, H2, 2012

Cervical Dysplasia Global Clinical Trials Review, H2, 2012

Publisher Name » GlobalData

Published Date » 2012-07-31

No. Of Pages » 69

Description
Table of Content
Related Reports
Request Sample
Enquiry
Check Discount

GlobalData's clinical trial report, Cervical Dysplasia Global Clinical Trials Review, H2, 2012" provides data on the Cervical Dysplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cervical Dysplasia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cervical Dysplasia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Cervical Dysplasia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Cervical Dysplasia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cervical Dysplasia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Cervical Dysplasia 19
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Cervical Dysplasia Therapeutics Clinical Trials 23
Prominent Drug Comparison 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Preventive Oncology International Inc 25
Clinical Trial Overview of Preventive Oncology International Inc 25
Eisai Inc. 26
Clinical Trial Overview of Eisai Inc. 26
Photocure ASA 27
Clinical Trial Overview of Photocure ASA 27
Clinical Trial Overview of Top Universities / Institutes / Hospitals 28
Catharina Ziekenhuis Eindhoven 28
Clinical Trial Overview of Catharina Ziekenhuis Eindhoven 28
New York Downtown Hospital 29
Clinical Trial Overview of New York Downtown Hospital 29
Teikyo University 30
Clinical Trial Overview of Teikyo University 30
Chiang Mai University 31
Clinical Trial Overview of Chiang Mai University 31
Planned Parenthood League of Massachusetts 32
Clinical Trial Overview of Planned Parenthood League of Massachusetts 32
Les Hopitaux Universitaires de Strasbourg 33
Clinical Trial Overview of Les Hopitaux Universitaires de Strasbourg 33
Mayo Clinic 34
Clinical Trial Overview of Mayo Clinic 34
The University of Tokyo Hospital 35
Clinical Trial Overview of The University of Tokyo Hospital 35
Aarhus University 36
Clinical Trial Overview of Aarhus University 36
Northwestern University 37
Clinical Trial Overview of Northwestern University 37
University of Copenhagen 38
Clinical Trial Overview of University of Copenhagen 38
McMaster University 39
Clinical Trial Overview of McMaster University 39
University Hospital, Tours 40
Clinical Trial Overview of University Hospital, Tours 40
Dana-Farber Cancer Institute 41
Clinical Trial Overview of Dana-Farber Cancer Institute 41
Hospices Civils de Lyon 42
Clinical Trial Overview of Hospices Civils de Lyon 42
University of Tennessee 43
Clinical Trial Overview of University of Tennessee 43
Emory University 44
Clinical Trial Overview of Emory University 44
Washington University School of Medicine 45
Clinical Trial Overview of Washington University School of Medicine 45
The University of Texas M. D. Anderson Cancer Center 46
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 46
Five Key Clinical Profiles 47

Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 69

List of Tables

Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Cervical Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Cervical Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11
Cervical Dysplasia Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Cervical Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 13
Cervical Dysplasia Therapeutics Clinical Trials, G7 Countries, 2012* 14
Cervical Dysplasia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Phase, 2012* 16
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 17
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18
Cervical Dysplasia Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 19
Cervical Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 20
Cervical Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 22
Cervical Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 23
Cervical Dysplasia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 24
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Preventive Oncology International Inc, 2012* 25
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 26
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Photocure ASA, 2012* 27
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Catharina Ziekenhuis Eindhoven, 2012* 28
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by New York Downtown Hospital, 2012* 29
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Teikyo University, 2012* 30
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiang Mai University, 2012* 31
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Planned Parenthood League of Massachusetts, 2012* 32
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Hopitaux Universitaires de Strasbourg, 2012* 33
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 34
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2012* 35
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012* 36
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 37
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Copenhagen, 2012* 38
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2012* 39
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2012* 40
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 41
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2012* 42
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tennessee, 2012* 43
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 44
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2012* 45
Cervical Dysplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 46

List of Figures

Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Cervical Dysplasia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10
Cervical Dysplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
Cervical Dysplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Cervical Dysplasia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 13
Cervical Dysplasia Therapeutics Clinical Trials, G7 Countries (%), 2012* 14
Cervical Dysplasia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 16
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 17
Cervical Dysplasia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18
Cervical Dysplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 20
Cervical Dysplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 21
Cervical Dysplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 23
Cervical Dysplasia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 24
GlobalData Methodology 67

Related Reports

Home Healthcare Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018

Oct 22, 2012 | By - Transparency Market Research

This report is an effort to identify factors, which will be the driving force behind the home healthcare market and sub-markets in the next few years. The report provides extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report has segregated the home healthcare industry in terms of...

Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth

Oct 1, 2012 | By - GBI Research

Biopharmaceutical Manufacturing in India, China and South Korea Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth GBI Research, the leading business intelligence provider has released its latest research report, Biopharmaceutical Manufacturing in India, China and South Korea Regulatory Framework, Infrastructure Support...

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market

Nov 1, 2012 | By - GBI Research

Gastrointestinal Disorders Therapeutics Market to 2018 Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market GBI Research, the leading business intelligence provider, has released its latest research, Gastrointestinal Disorders Therapeutics Market to 2018 Novel Agents Targeting Irritable...

Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans

Sep 30, 2012 | By - GBI Research

Biodefense Industry Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans GBI Research, the leading business intelligence provider has released its latest research report, Biodefense Industry Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans. The report focuses on the key insights into the biodefense...

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

Jul 31, 2012 | By - GBI Research

GBI Research, the leading business intelligence provider, has released its latest research, e-Clinical Trial Solutions Market to 2018 Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies, which provides key data and analysis of the major factors affecting the market for eClinical trial solutions in the...

Upcoming Reports:

FAME (Fatty Acid Methyl Esters) - Global Industry Analysis, Market Share, Size, Growth, Trends and Forecast, 2012 - 2018

By - Transparency Market Research

Fatty acid methyl esters (FAME) are produced by reacting fatty acids and methanol. They are also present in biodiesels and are similar to those in conventional diesel but expel lower concentrations of toxic emissions and thus, are non-toxic and biodegradable. They are produced from vegetable oils and animal fats by the process of transesterification. Rapeseed, soybean, UCO, palm oils, sunflower and animal fat are used as raw materials for the production of FAME. FAME have high oxidation stability and hence can be used under normal conditions. The use of these esters...

Neurology Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

By - Transparency Market Research

The neurological devices market is one of the fastest growing segments in the medical devices industry. With continuous improvements in the neurology devices, market is set to witness double digit growth rate. A wide range of neurology devices are available in the market depending on the complexity of the illness. This market addresses a large pool of patients with the risk of neurological disorders like Parkinson’s disease, Alzheimer’s disease, epilepsy, etc. Although the neurology devices market is dominated by hemorrhagic strokes devices, there also exists...

Energy Retrofits Systems Market - Global Industry Analysis, Market Size, Share, Growth, Trends, And Forecast, 2012 - 2018

By - Transparency Market Research

The rising demand for energy and limited/inefficient storage systems are proving inadequate to satisfy the demand for industrial energy requirements. Researchers are aggressively and continuously working in order to develop and manufacture effective and efficient systems that will store and distribute the required amount of energy globally. Energy retrofits are the adjustment or addition to the existing energy consuming equipment that are utilized in commercial outlets and in buildings. The desire to reduce energy costs required to operate the industry is the primary driving...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)

Tel: +1-518-618-1030
Email: sales@researchmoz.com

Select License type:

Share this report

Scoop.it

Latest Reports

Sep 14, 2012

The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...

Now At-Home TB Diagnosis Looks Possible

Sep 14, 2012

According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...

China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects

Sep 14, 2012

Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...

Battling against flu, vaccination necessary for health workers

Sep 14, 2012

To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...

Japan to Cut Import Duties on Indian Generic Drugs Imports

Sep 14, 2012

The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...